Epidemiology of Human Metapneumovirus Infection in a Community Setting, Seattle, Washington, USA - Takeaways - MDSpire

Epidemiology of Human Metapneumovirus Infection in a Community Setting, Seattle, Washington, USA

  • By

  • Annalyse Elias-Warren

  • Julia C Bennett

  • Chidozie D Iwu

  • Lea M Starita

  • Jeremy Stone

  • Ben Capodanno

  • Robin Prentice

  • Peter D Han

  • Zack Acker

  • Sally B Grindstaff

  • David Reinhart

  • Jennifer K Logue

  • Caitlin R Wolf

  • Michael Boeckh

  • Kevin Kong

  • Hong Xie

  • Geon Kim

  • Alexander L Greninger

  • Amanda C Perofsky

  • Cécile Viboud

  • Timothy M Uyeki

  • Janet A Englund

  • Pavitra Roychoudhury

  • Helen Y Chu

  • July 16, 2025

  • 0 min

Share

  • 1

    Human metapneumovirus (hMPV) infections were studied in Seattle from 2018 to 2022, focusing on community and clinical settings.

  • 2

    hMPV positivity was significantly higher in clinical specimens (3.9%) compared to community specimens (0.6%).

  • 3

    Children aged 0–4 years exhibited the highest hMPV positivity rates in both clinical (4.9%) and community (1.7%) settings.

  • 4

    Lower household income and recent international travel were identified as risk factors for hMPV positivity.

  • 5

    The study observed co-circulation of hMPV subtypes in community and clinical settings, with subtype B1 increasing post-pandemic.

Original Source(s)

Epidemiology of Human Metapneumovirus Infection in a Community Setting, Seattle, Washington, USA

  • by Annalyse Elias-Warren, Julia C Bennett, Chidozie D Iwu, Lea M Starita, Jeremy Stone, Ben Capodanno, Robin Prentice, Peter D Han, Zack Acker, Sally B Grindstaff, David Reinhart, Jennifer K Logue, Caitlin R Wolf, Michael Boeckh, Kevin Kong, Hong Xie, Geon Kim, Alexander L Greninger, Amanda C Perofsky, Cécile Viboud, Timothy M Uyeki, Janet A Englund, Pavitra Roychoudhury, Helen Y Chu

  • July 16, 2025

Related Content

Enhancing cancer vaccine efficacy via electrostatic engineering of an FcγR-targeted protein

Immune remodeling and metabolic reprogramming in chronic fatigue: insights into GPCR signaling and epigenetic regulation

The latest developments on Ebola, hepatitis B, long Covid